LDL-cholesterol, HDL-cholesterol or triglycerides--which is the culprit?

[1]  M. Taskinen,et al.  A low high density lipoprotein (HDL) level is associated with carotid artery intima-media thickness in asymptomatic members of low HDL families. , 2002, Atherosclerosis.

[2]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[3]  J. Dekker,et al.  Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease , 2002, Diabetologia.

[4]  F. Ruschitzka,et al.  High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men , 2002, Circulation.

[5]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[6]  M. Taskinen,et al.  Endothelial dysfunction in men with small LDL particles. , 2000, Circulation.

[7]  M. Harris.  Health care and health status and outcomes for patients with type 2 diabetes. , 2000, Diabetes care.

[8]  S. Jackson,et al.  Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus. , 2000, Circulation.

[9]  J. Viikari,et al.  Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men. , 1999, Atherosclerosis.

[10]  A. Hamsten,et al.  LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[11]  V. Ai,et al.  Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. , 1999, The Journal of clinical endocrinology and metabolism.

[12]  M. Taskinen,et al.  Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. , 1999, Diabetes care.

[13]  G. Lewis,et al.  Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. , 1999, The Journal of clinical investigation.

[14]  M. Laakso,et al.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.

[15]  I. Stratton,et al.  Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23) , 1998, BMJ.

[16]  S. Haffner.  Management of Dyslipidemia in Adults With Diabetes , 1998, Diabetes Care.

[17]  R. Krauss,et al.  Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[18]  M. Taskinen,et al.  Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus , 1997, The Lancet.

[19]  R. Krauss,et al.  Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. , 1996, JAMA.

[20]  M. Laakso,et al.  Lipids and Lipoproteins Predicting Coronary Heart Disease Mortality and Morbidity in Patients With Non-insulin-dependent Diabetes , 1993 .

[21]  M. Taskinen,et al.  Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[22]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[23]  S. Yusuf.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .

[24]  M. Taskinen,et al.  Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease. , 1994, Journal of lipid research.